How to purchase amivantamab in the country and recommend regular channels

Amivantamab (amivantamab) is a new type of bispecific antibody, mainly used to treat patients with non-small cell lung cancer with EGFR exon 20 insertion mutations. This drug has just been launched in China. Due to the short time on the market, the market supply has not yet been fully popularized, making it difficult for some patients to purchase it directly in domestic hospitals or pharmacies. For patients who are in urgent need of medication, it is especially important to understand the purchasing channels.

At present, there are still certain challenges in purchasing evantumumab through formal domestic channels. Patients should first consult the oncology department or oncology clinic of a regular hospital about the medication. Some large tertiary hospitals may have begun to introduce this drug. Patients can purchase the drugs at the hospital pharmacy or its designated drug supply chain with a doctor's prescription to ensure the regularity and safety of the drugs. At the same time, patients are advised to pay attention to the latest developments in the National Medical Products Administration (NMPA) and local medical insurance policies to learn about progress in the inclusion of drugs in medical insurance or the convenience of drug purchase.

In addition to domestic channels, some patients will consider obtaining evantumumab through overseas markets. It is understood that evantumumab is already on the market in Hong Kong, China, and the price of the original research version is about 10,000 yuan. Hong Kong's drug regulatory system is mature, and the quality and source of drugs are reliable. Patients can purchase them through regular medical institutions or certified pharmacies in Hong Kong. It should be noted that cross-border drug purchases must abide by relevant laws and regulations, and you should consult a doctor in advance to confirm the medication regimen and dosage to avoid the risk of misuse due to different drug specifications.

In general, as a newly launched innovative anti-cancer drug, domestic purchase channels for evantumumab are still gradually improving. Patients should give priority to regular hospitals and pharmacies to obtain drugs to ensure drug safety and efficacy. For patients who are temporarily unable to obtain drugs domestically, they may consider overseas regular channels, but be sure to choose carefully to avoid fake and shoddy products. At the same time, we actively pay attention to changes in domestic drug policies and look forward to more adequate supply in the domestic market and more convenient drug purchase in the future.

Reference: https://go.drugbank.com/drugs/